Cargando…
Targeting gasdermin E in neurodegenerative diseases
Neel et al. identified pathophysiologic clues linking gasdermin-E (GSDME) with frontotemporal dementia and amyotrophic lateral sclerosis.(1) Therapeutic studies targeting GSDME may provide a viable approach for neurodegenerative diseases.
Autores principales: | Zhou, Zhi Dong, Yi, Ling Xiao, Tan, Eng King |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313929/ https://www.ncbi.nlm.nih.gov/pubmed/37343522 http://dx.doi.org/10.1016/j.xcrm.2023.101075 |
Ejemplares similares
-
Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022) -
Factoring in the force: A novel role for eIF6
por: Wilson, Darren Graham Samuel, et al.
Publicado: (2022) -
Gasdermin E: A Prospective Target for Therapy of Diseases
por: Liao, Xiu-Xiu, et al.
Publicado: (2022) -
The ides of MARCH5: The E3 ligase essential for peroxisome degradation by pexophagy
por: Platta, Harald W., et al.
Publicado: (2021) -
Dynamic Rac1 inhibition by CYRI helps cells drink, but stops them from driving
por: King, Jason S.
Publicado: (2021)